The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business ...

But the bill also would prohibit mRNA vaccines, like those developed by Pfizer and Moderna to combat COVID-19, Shippy told ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Republican Rep. Brandon Shippy wants to put a moratorium on mRNA vaccines, based on his ignorance about them. | Opinion ...

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

On March 11 th 2020, the World Health Organization (WHO) declared that COVID-19 was a global pandemic. In the fight against COVID-19, two FDA-approved mRNA vaccines were developed by Pfizer/BioNTech ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...